These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 8424263)

  • 21. Reexamination of human T cell lymphotropic virus (HTLV-I/II) prevalence.
    Zucker-Franklin D; Pancake BA; Marmor M; Legler PM
    Proc Natl Acad Sci U S A; 1997 Jun; 94(12):6403-7. PubMed ID: 9177230
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Determination of the true prevalence of infection with the human T-cell lymphotropic viruses (HTLV-I/II) may require a combination of biomolecular and serological analyses.
    Pancake BA; Zucker-Franklin D; Marmor M; Legler PM
    Proc Assoc Am Physicians; 1996 Nov; 108(6):444-8. PubMed ID: 8956367
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Human T-cell lymphotropic virus in patients infected with HIV-1: molecular epidemiology and risk factors for transmission in Piaui, Northeastern Brazil.
    de Oliveira EH; Oliveira-Filho AB; Souza LA; da Silva LV; Ishak MO; Ishak R; Vallinoto AC
    Curr HIV Res; 2012 Dec; 10(8):700-7. PubMed ID: 23016526
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Human T-lymphotropic virus and transfusion safety: does one size fit all?
    Marano G; Vaglio S; Pupella S; Facco G; Catalano L; Piccinini V; Liumbruno GM; Grazzini G
    Transfusion; 2016 Jan; 56(1):249-60. PubMed ID: 26388300
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evidence in Gabon for an intrafamilial clustering with mother-to-child and sexual transmission of a new molecular variant of human T-lymphotropic virus type-II subtype B.
    Tuppin P; Gessain A; Kazanji M; Mahieux R; Cosnefroy JY; Tekaia F; Georges-Courbot MC; Georges A; de Thé G
    J Med Virol; 1996 Jan; 48(1):22-32. PubMed ID: 8825706
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The epidemiology of human T-cell lymphotropic virus types I and II in Canadian blood donors.
    O'Brien SF; Goldman M; Scalia V; Yi QL; Fan W; Xi G; Dines IR; Fearon MA
    Transfus Med; 2013 Oct; 23(5):358-66. PubMed ID: 23859527
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Higher human T lymphotropic virus (HTLV) provirus load is associated with HTLV-I versus HTLV-II, with HTLV-II subtype A versus B, and with male sex and a history of blood transfusion.
    Murphy EL; Lee TH; Chafets D; Nass CC; Wang B; Loughlin K; Smith D;
    J Infect Dis; 2004 Aug; 190(3):504-10. PubMed ID: 15243924
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Strategies for diagnosis of HTLV-I and -II.
    Thorstensson R; Albert J; Andersson S
    Transfusion; 2002 Jun; 42(6):780-91. PubMed ID: 12147033
    [TBL] [Abstract][Full Text] [Related]  

  • 29. HTLV infection in ELISA-negative blood donors.
    Zehender G; Girotto M; De Maddalena C; Francisco G; Moroni M; Galli M
    AIDS Res Hum Retroviruses; 1996 May; 12(8):737-40. PubMed ID: 8744584
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Detection of HTLV-I and -II in Scottish blood donor samples and archive donations.
    Davidson F; Lycett C; Jarvis LM; Kerr D; Lumley S; Petrik J; Dow BC
    Vox Sang; 2006 Oct; 91(3):231-6. PubMed ID: 16958835
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Southernmost carriers of HTLV-I/II in the world.
    Cartier L; Araya F; Castillo JL; Zaninovic V; Hayami M; Miura T; Imai J; Sonoda S; Shiraki H; Miyamoto K
    Jpn J Cancer Res; 1993 Jan; 84(1):1-3. PubMed ID: 8449820
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Determination of anti-HTLV-I/II antibodies: Experience in 28,897 blood donations in Buenos Aires].
    Blejer JL; Saguier MC; Salamone HJ; Carreras LA
    Sangre (Barc); 1995 Dec; 40(6):447-51. PubMed ID: 8850226
    [TBL] [Abstract][Full Text] [Related]  

  • 33. HTLV-I and HTLV-II infections in volunteer blood donors and high-risk groups in Lebanon.
    Naman R; Klayme S; Naboulsi M; Mokhbat J; Jradi O; Ramia S
    J Infect; 2002 Jul; 45(1):29-31. PubMed ID: 12217728
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Confirmation of the presence in Cuba of human T-cell lymphotropic virus type I using the polymerase chain reaction].
    Rolo Gómez F; De Armas MB; Mato Luis J; Lubián Caballero AL; Díaz Torres H
    Rev Cubana Med Trop; 1997; 49(3):204-8. PubMed ID: 9685988
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Human T-lymphotropic virus laboratory testing of maternal blood at time of cord blood donations and clinical implications.
    Glasser L; Cyrus S; Machan JT; Mapother J
    Transfusion; 2013 Jun; 53(6):1302-8. PubMed ID: 22998131
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The origin and evolution of human T-cell lymphotropic virus types I and II.
    Suzuki Y; Gojobori T
    Virus Genes; 1998; 16(1):69-84. PubMed ID: 9562892
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High Ratio of Human T Cell Lymphotropic Virus Transmission and Prevalence of Human T Cell Lymphotropic Virus Type 1-Associated Diseases in Brazilian Family Groups Followed Up by the GIPH Cohort.
    Romanelli LCF; Figueiredo GGR; Ribeiro MA; Martins ML
    AIDS Res Hum Retroviruses; 2024 Jun; 40(6):401-407. PubMed ID: 38299509
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transfusion-transmitted human T-cell lymphotropic virus type I infection in Taiwan: a true risk and occasional coinfection with hepatitis C virus shown in a prospective study.
    Wang JT; Lin MT; Chen PJ; Sheu JC; Lin JT; Wang TH; Chen DS
    Blood; 1994 Aug; 84(3):934-40. PubMed ID: 7913844
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Blocking vertical transmission of human T cell lymphotropic virus type 1 and 2 through breastfeeding interruption.
    Ribeiro MA; Martins ML; Teixeira C; Ladeira R; Oliveira Mde F; Januário JN; Proietti FA; Carneiro-Proietti AB
    Pediatr Infect Dis J; 2012 Nov; 31(11):1139-43. PubMed ID: 22683674
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sensitivity and specificity of human T-lymphotropic virus (HTLV) types I and II polymerase chain reaction and several serologic assays in screening a population with a high prevalence of HTLV-II.
    Liu H; Shah M; Stramer SL; Chen W; Weiblen BJ; Murphy EL
    Transfusion; 1999; 39(11-12):1185-93. PubMed ID: 10604244
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.